Can contrast-enhanced ultrasound with perfluorobutane add value in detection of hepatocellular carcinoma in cirrhosis during surveillance?
Quant Imaging Med Surg
.
2019 Aug;9(8):1466-1469.
doi: 10.21037/qims.2019.07.10.
Authors
Antonio Giorgio
1
,
Massimo De Luca
2
,
Pietro Gatti
3
,
Paolo Matteucci
4
,
Valentina Giorgio
5
Affiliations
1
Liver Unit and Interventional Ultrasound Unit, Athena Clinical Institute, Piedimonte Matese (CE), Caserta, Italy.
2
Liver Unit, Cardarelli Hospital, Largo A Cardarelli, Naples, Italy.
3
Internal Medicine Unit, Brindisi General Hospital, Brindisi, Italy.
4
Radiation Oncology Unit, Campus Biomedico, Rome, Italy.
5
Fondazione Policlinico A. Gemelli IRCCS, Department of Woman and Child Health and Public Health, Largo A Gemelli, Roma, Italy.
PMID:
31559175
PMCID:
PMC6732065
DOI:
10.21037/qims.2019.07.10
No abstract available
Publication types
Editorial
Comment